navigated rTMS of motor cortex
DeviceNavigated repetitive transcranial magnetic stimulation of the motor cortex ( 10 Hz ) ,5 daily sessions per week for two weeks.
Other names: Navigated, rTMS
NCT Number: NCT02277912
The aim of the study is to evaluate the analgesic effects of navigated repetitive transcranial magnetic stimulation in central post stroke pain. MRI based navigation is used to determine the exact locations for stimulation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Central post stroke pain is often very resistant to treatment. TMS has been shown to be a promising tool in treating difficult pain conditions. The best sites for stimulation are still not known and navigation has been used only in few studies.
The aim is to evaluate the analgesic effects of Navigated Repetitive Transcranial Magnetic Stimulation ( nrTMS ) on pain in a three armed crossover study. The navigation is done by using magnetic resonance imaging and stereotactic camera system. The three arms include stimulation to M1, S2 and sham stimulation to M1. 10 Hz repetitive stimulation is given to a specified location once a day 5 days a week for two weeks in each of the three arms. A months washout period is kept between each arm of the study.
Pain and other variables are followed before, during and after the study for 6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Navigated repetitive transcranial magnetic stimulation of the motor cortex ( 10 Hz ) ,5 daily sessions per week for two weeks.
Other names: Navigated, rTMS
Navigated repetitive transcranial magnetic stimulation of the secondary somatosensory cortex ( 10 Hz ), 5 daily sessions per week for two weeks
Other names: Navigated, rTMS
Repetitive SHAM transcranial magnetic stimulation of the motor cortex ( 10Hz) 5 daily sessions per week for two weeks.
Other names: Navigated, rTMS, Placebo
Time frame: 1 month after each arm of the study
Patients will keep a pain diary for one week before stimulation and for two weeks after the stimulation. A nurse will call the patient one month after the last stimulation.
Time frame: One week after each arm of the study and 6 months after the last one
Questionnaire EQ-5D
Time frame: One week after each arm of the study and 6 months after the last stimulation
Questionnaire
Time frame: 2,3,4,5 and 6 months after the last stimulation
Phone call ( Numeric Rating Scale (NRS) in rest and movement )
Time frame: One week before and after each arms stimulations
Changes in the irritability of the motor cortex and somatosensory cortex
Time frame: From the start to the end of the study, on average 12 months per patient.
Adverse effects are followed actively
Time frame: One week before and after each arm of the study
Nine hole peg, Pinch and Jamar
Time frame: One week before and after each arm of the study
Conditioned pain modulation (CPM)
Time frame: No time frame, just a blood sample
Evaluation of genetical properties in terms of TMS related pain reduction
Helsinki University Central Hospital
Other
Efficacy of Navigated Repetitive Transcranial Magnetic Stimulation in Treatment of Central Post Stroke Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07202455
Brain Diseases, Cardiovascular Diseases
Clermont-Ferrand, France
View Trial DetailsNCT02148588
Central Post Stroke Pain
St Louis, Missouri, United States
View Trial DetailsNCT06387914
Central Post Stroke Pain, Nervous System Diseases
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial Details